165 filings
Page 2 of 9
8-K
vbge55 ed9t
10 Jan 23
Regulation FD Disclosure
8:15am
8-K
ukltnh
6 Jan 23
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:15pm
8-K
j2s f1i9bgn
29 Nov 22
Departure of Directors or Certain Officers
9:01am
8-K
ouw0z zon0r
28 Oct 22
AbbVie Reports Third-Quarter 2022 Financial Results
7:48am
8-K
v56y smbecihf
17 Oct 22
Departure of Directors or Certain Officers
9:05am
8-K
hf5we210m
14 Oct 22
Departure of Directors or Certain Officers
5:02pm
8-K
zvdrgzl gj2v
5 Oct 22
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:14pm
8-K
zd9l2
29 Jul 22
AbbVie Reports Second-Quarter 2022 Financial Results
7:49am
8-K
lz0eqj68m 29h
6 Jul 22
Guidance Including the Impact of Acquired IPR&D and Milestones Expense Incurred During the Second Quarter of 2022
4:17pm
8-K
1wl5ofhn
29 Jun 22
Amendments to Articles of Incorporation or Bylaws
8:30am
8-K
yt7wg9mxlcdkkx
28 Jun 22
Departure of Directors or Certain Officers
9:16am
8-K
7njvvsir
11 May 22
Submission of Matters to a Vote of Security Holders
5:06pm
8-K
0z12aouvnh4zcaky
29 Apr 22
AbbVie Reports First-Quarter 2022 Financial Results
9:00am
8-K
l7ac99wy8 n6t
29 Apr 22
AbbVie Reports First-Quarter 2022 Financial Results
7:45am
8-K
p8gy4frdmco
21 Apr 22
Reconciliation of Reported GAAP and Non-GAAP Results to Revised Non-GAAP Results
5:12pm
8-K
o3b6y2nd89gu1zy6ojh
13 Apr 22
Departure of Directors or Certain Officers
9:15am
8-K
33zyepl 097tdgv
4 Mar 22
Departure of Directors or Certain Officers
4:16pm
8-K
py07wechl4p
2 Feb 22
AbbVie Reports Full-Year and Fourth-Quarter 2021 Financial Results
7:48am
8-K
kza3bl
17 Dec 21
Departure of Directors or Certain Officers
5:02pm
8-K
3rnj94k
16 Dec 21
Departure of Directors or Certain Officers
5:02pm